Thyroid-associated orbitopathy in patients with Hashimoto's thyroiditis: A case report

Polskie Archiwum Medycyny Wewnetrznej

Volumn 118, Issue 5, 2008, Pages 318-321

  Grzesiuk, Wiesław ^a   Szydlarska, Dorota ^a   Pragacz, Aneta ^b   Bar Andziak, Ewa ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Independent Public Healthcare Institution   (Poland)

Author keywords

Autoimmune disease; Hashimoto's disease; Orbitopathy; Thyroid antibodies

Indexed keywords

CYANOCOBALAMIN; LEVOTHYROXINE; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CYTOLOGY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG PULSE THERAPY; HASHIMOTO DISEASE; HUMAN; HYPOTHYROIDISM; LABORATORY TEST; MALE; MORBIDITY; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT DISEASE; ORBITOPATHY; PERNICIOUS ANEMIA; PHYSICAL EXAMINATION; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME;

ADULT; ANEMIA, PERNICIOUS; AUTOANTIBODIES; GRAVES OPHTHALMOPATHY; HASHIMOTO DISEASE; HUMANS; MALE; METHYLPREDNISOLONE; THYROTROPIN; THYROXINE;

EID: 45249090835     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.400     Document Type: Article

References (13)

1. Krassas GE, Wiersinga WM. Thyroid eye disease: current concepts and the EUGOGO perspective. Thyroid International. 2005; 4: 3-4.
2. Shirakawa H, Amemiya T, Kasagi K, et al. Hashimoto disease with hyperthyroid ocular signs. Metab Pediat Ophthalmol. 1981; 5: 213-218.
3. Khoo TK, Bahn RS. Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies. Thyroid. 2007; 17: 1013-1018.
4. Wiersinga WM, Perrot P, Kahaly GJ, et al. Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol. 2006; 155: 387-389.
5. Jarza̧b B, Lewiński A, Płaczkiewicz-Jankowska E. Choroby tarczycy. In: Szczeklik A, ed. Choroby wewnȩtrzne. Kraków, Medycyna Praktyczna, 2005: 1033-1082.
6. Ludgate ME. Animal models of thyroid-associated ophthalmopathy. Thyroid. 2002; 12: 205-208.
7. Smith BR, Sanders J, Furmaniak J. The receptor antibodies. Thyroid. 2007; 17: 923-938.
8. Eckstein AK, Plicht M, Lax H, et al. Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab. 2006; 91: 3464-3470.
9. Nagayama Y. Animals models of Graves' hyperthyroidism. Thyroid. 2007; 17: 981-987.
10. Ludgate M. Animals models of Graves' disease. Eur J Endocrinol. 2000; 142: 1-8.
11. Niemczyk S, Panasiuk-Jarzyło E, Matuszkiewicz-Rowińska J, Niemczyk L. Ocena przydatności obecności przeciwciał przeciw tyreoperoksydazie (TPOAb) u chorych ze schyłkowa̧ niewydolnościa̧ nerek. Pol Arch Med Wewn. 2004; 111: 687-692.
12. Owecki M, Sowiński J. Oftalmopatia tarczycowa w przebiegu choroby Gravesa i Basedowa ze współistnieja̧cym guzem prawego oczodołu i towarzysza̧ca̧ hiperprolaktynemia̧ - opis przypadku. Pol Arch Med Wewn. 2004; 112: 1335-1339.
13. Kozłowska J, Jabłońska J, Skórka B, et al. Współwystȩpowanie autoimmunologicznego zapalenia wa̧troby typu III i autoimmunologicznego zapalenia tarczycy typu III (choroba Gravesa i Basedowa). Pol Arch Med Wewn. 2004; 112: 1473-1478.